International reporting with regional context and cross-border impact.
Strategic angle: New York Mets shortstop Francisco Lindor made his spring training debut on Sunday, going 1 for 3 with a run scored in his first game back after Feb. 11 hand surgery.
Strategic angle: Collaboration aims to enhance resource security and reduce dependence on foreign supplies.
Strategic angle: Latest insights on cobalt pricing and market trends in China.
Strategic angle: Everybody is clueless, and when you are clueless, you are scared.
Strategic angle: The killing of Charlie Kirk galvanised a transatlantic campaign against abortion. But will it succeed in shifting Britain's pro-choice consensus?
Strategic angle: A new study reveals that workplace frustration and distrust contribute to support for the Rassemblement National.
Strategic angle: A nuclear expert highlights the ongoing concerns surrounding Iran's uranium reserves.
Strategic angle: Research reveals the potential of cannabinoids in combating Alzheimer's disease by removing harmful proteins.
Governor Lombardo visits the Thacker Pass lithium project to discuss its significance for Nevada's economy.
Strategic angle: Insights into the role of batteries in clean technology investments.
Strategic angle: Analysis and reconstruction of a warp-weighted loom from the second millennium BC site of Cabezo Redondo, Spain, provides an unprecedented glimpse into the development of textile technology in the Bronze Age western Mediterranean.
Strategic angle: "We don’t build them."
Strategic angle: Fresh spy shots show two facelifted E-Hybrid prototypes getting ready for a debut this year.
Strategic angle: Jessie Buckley shines in a stunning red Chanel gown at the Dolby Theatre.
Strategic angle: New crash data from AAA shows hit-and-run incidents rising across the U.S., raising serious safety concerns.
Strategic angle: Exploring the economic motivations behind Trump's interest in Greenland.
Strategic angle: Viking Holdings expands its fleet with the latest addition to its river cruise offerings.
Strategic angle: Merck & Co. is taking strategic steps to address the impending loss of exclusivity for KEYTRUDA.
Strategic angle: Abbott Laboratories introduces a new product aimed at improving cardiovascular care in the Indian market.
Strategic angle: Analysts are optimistic about Gilead Sciences' future growth, leading to recent upgrades.